Impact of HIV co-infection on hepatitis B prevention and control: a view from sub-Saharan Africa

References

• UNAIDS. AIDS epidemic update, December 2007. http//data.unaids.org/pub/EPISlides/2007/2 007 epiupdate en.pdf [Accessed February 2008]
   Google Scholar
• Department of Health, South Africa. National HIV and Syphilis antenatal roprevalence survey in South Africa 2002. Pretoria, South Africa, 2003.
   Google Scholar
• The EASL Jury. EASL International Consensus Conference on Hepatitis B, 13–14 September 2002, Geneva, Switzerland. Consensus Statement (Long Statement). JHepa to/2003; 39\(Suppl 1): S3–S25.
   Google Scholar
• Centres for Disease Control and Prevention, 2003. www.cdc.gov/ncidod/diseases/hepatitis/slideset/ [Accessed February 2008]
   Google Scholar
• Kew MC. Progress towards the comprehensive control of hepatitis B in Africa: a view from SouthAfrica. Gut1996; 38\(Supp12): S31–S36.
   Google Scholar
• Mphahlele MJ, Francois G, Kew MC, Van Damme P, Hoosen AA, Meheus A. Epidemiology and control of hepatitis B: implications for eastern and southern Africa. South Aff J Epidemio] Infect2002; 17: 12–17.
   Google Scholar
• Ayoola EA. Viral hepatitis in Africa. In: Zuckerman AJ, ed. Wral Hepatitis andLiver Disease. New York: Alan R Liss, 1988: 161–169.
   Google Scholar
• Kiire CF. The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa. Gut1996; 38\(Suppl. 2): S5–S12.
   Google Scholar
• Davis LG, Weber DJ, Lemon SM. Horizontal transmission of hepatitis virus. Lancet1989;1: 889–893.
   Google Scholar
• Dabis F, Ekpini ER. HIV-1/AIDS and maternal and child health in Africa. Lancet.2002; 359:2097–2104.
   Google Scholar
• Cooley L, Sasadeusz J. Clinical and virological aspects of hepatitis B co-infection in individuals infected with human immunodeficiency virus type-1. J Clin Wro/2003; 26: 185–193.
   Google Scholar
• Kamiya N. The mechanisms of action of antivirals against hepatitis B virus infection. JAntimicrobial Chem2003; 51: 1085–1089.
   Google Scholar
• Angus P, Locarnini S. Lamivudine-resistant hepatitis B virus and ongoing lamivudine therapy: stop the merry-go-round, its time to get off. Antivir Ther2004; 9: 145–148.
   Google Scholar
• Bartholomeusz A, Tehan BG, Chalmers DK. Comparison of the HBV and HIV polymerase, and antiviral resistance mutations. Antivir Ther 2004; 9: 149–160.
   Google Scholar
• Karayiannis P. Hepatitis B virus: old, new and future approaches to antiviral treatment. JAntimicrobChem2003; 51:761–785.
   Google Scholar
• Locarnini S. Hepatitis B virus surface and polymerase gene variants: potential virological and clinical significance. Hepatology 1998; 27: 294–297.
   Google Scholar
• Luscombe CA, Locarnini SA. Avi-Hepadnaviridae. In: Zuckerman AJ, Thomas HC, eds. Wral Hepatitis 1998: 115–128.
   Google Scholar
• Hu KQ. Occult hepatitis B virus infection and its clinical implications. JWralHepat2002; 9:243–257.
   Google Scholar
• Grob P, Jilg W, Bornhak H, eta]. Serological pattern 'anti-HBc alone': report on a workshop. JMed Wro/2000; 62:450–455.
   Google Scholar
• Mphahlele MJ, Moloto MJ. Detection of HBV DNA from serologically negative or 'silent' HBV infections - viral or host factors? SAff Med J 2002; 92:613–615.
   Google Scholar
• Hofer M, Joller-Jemelka HI, Grob PJ, Lathy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur JClinMcrobiol InfectDis 1998; 17:6–13.
   Google Scholar
• Xiang J, George SL, Klinzman D, Stapleton JT. HBV viraemia in HIV-positive individuals. Proceedings of the 10th International Symposium on Viral Hepatitis and Liver Disease, 9–13 April 2000, Atlanta, Georgia, USA (Abstract B033).
   Google Scholar
• Piroth L, Binquet C, Vergne M, eta]. The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J Hepato12002; 36: 681–686.
   Google Scholar
• Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM. High risk of occult hepatitis B virus infection in HIV-positive patients from SouthAfrica. J Clin Wro/2006: 35:14–20.
   Google Scholar
• US Food and Drug Administration. www.fda.gov [Accessed February 2008]
   Google Scholar
• Operational Plan for Comprehensive HIV and AIDS Care, Management and Treatment for South Africa. Pretoria, South Africa, 19 November 2003.
   Google Scholar
• Fang CT, Chen PJ, Chen MY, eta]. Dynamics of plasma hepatitis B virus levels after highly active antiretroviral therapy in patients with HIV infection. JHepatology2003; 39: 1028–1035.
   Google Scholar
• Gish R, Leung NW, Wang C, et al. Antiviral activity, safety and incidence of resistance in chronically infected hepatitis patients given once daily emtricitabine for 2 years. Hepatology 2002; 36:372A (Abstract 838).
   Google Scholar
• Xiong S, Yang H, Westland C, eta]. Resistance surveillance of HBeAg-chronic hepatitis B patients treated for two years with adefovir dipivoxil. Proceedings of the 11th International Symposium on Viral Hepatitis and Liver Disease, Sydney, Australia, 6–10 April 2003 (Abstract 779).
   Google Scholar
• Handema R, Terunuma H, Kasolo F, et al. Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1. AIDS Res Hum Retroviruses 2003; 19: 151–160.
   Google Scholar
• Selabe SG, Lukhwareni A, Leeuw YGM, eta]. Lamivudine-resistant (YMDD) strains in therapy-naïve occult hepatitis B patients co-infected with HIV. Proceedings of the 44th Congress of the Federation. of South African Societies of Pathology (FSASP), 4–7 July 2004, Cape Town, South Africa (Abstract MP 20).
   Google Scholar
• Gordon M, De Oliveira T, Bishop K, eta]. Molecular characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implications for vaccine and antiretroviral control strategies. J Wro/2003; 77:2587–2599.
   Google Scholar
• Pillay C, Bredell H, McIntyre J, Gray G, Morris L. HIV-1 subtype C reverse transcriptase sequences from drug-naive pregnant women in SouthAfrica. AIDSResHumRetroviruses2002; 18:605–610.
   Google Scholar
• Selabe SG, Song E, Burnett RJ, Mphahlele MJ. Identification of lamivudine-resistance HBV strains from South African hepatitis B chronic patients on lamivudine therapy. Proceedings of the 44th Congress of the Federation of South African Societies of Pathology (FSASP), 4–7 July 2004, Cape Town, SouthAfrica (Abstract MP 19).
   Google Scholar
• Benhamou Y, Bochet M, Thibualt V, et al. Long-term incidence of hepatitis B virus resistance to lamivudine in HIV-infected patients. Hepatology1999; 30: 1302–1306.
   Google Scholar
• Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2001; 34: 1225–1241.
   Google Scholar
• Soriano V, Miro JM, Garcia-Samaniego J, eta]. Consensus conference on chronic viral hepatitis and HIV: updated Spanish recommendations. JWralHepat2004; 11:2–17.
   Google Scholar
• Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infections. Hepatology 2002; 35: 182–189.
   Google Scholar
• Global Alliance for Vaccines and Immunisation. www.gavialliance.oreindex.php [Accessed February 2008]
   Google Scholar
• 40.Mphahlele MJ, Francois G. Hepatitis B in eastern and southern Africa at the onset of millennium. South Air J Epidemiol Inectf 2002; 17\(Supp13-4): 2–3.
   Google Scholar
• André F. Hepatitis B epidemiology in Asia, the Middle East and Africa. ccine2000;18(Suppl 1): S20–S22.
   Google Scholar
• 42.Wilson JN, Nokes DJ, Carman WF. The predicted pattern of emergence of vaccine-resistant hepatitis B: a cause for concern? 1h ccine 1999; 17: 973–978.
   Google Scholar
• Mphahlele MJ, Francois G, Kew MC, Hoosen A, Meheus A. Hepatitis B virus infection in eastern and southern Africa: epidemiology, clinical aspects and prevention. SouthAfrJEpidemiolInfect2002; 17(Suppl 3–4): 1–66.
   Google Scholar
• Moss WJ, Clements CJ, Halsey NA. Immunisation of children at risk of infection with human immunodeficiency virus. Bull LW Hlth Org 2003; 81:61–70.
   Google Scholar
• Fortuin M, Chotard J, Jack AD, eta]. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation. Lancet 1993; 341: 1129–1131.
   Google Scholar
• Aspinall S, Kocks DJ. Immunogenicity of a low-cost hepatitis B vaccine in the SouthAfrican Expanded Programme on Immunisation. S AffMedJ1998; 88:36–39.
   Google Scholar
• Whittle HC, Maine N, Pilkington J, et al. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. Lancet1995; 345: 1089–1092.
   Google Scholar
• 48.Viviani S, Jack A, Hall AJ, eta]. Hepatitis B vaccination in infancy in the Gambia: protection against carriage at 9 years of age. 1h ccine 1999; 17:2946–2950.
   Google Scholar
• Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA, Mphahlele MJ. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds. 1h ccine2001; 19:3919–3926.
   Google Scholar
• Schoub BD, Matai U, Singh B, Blackburn NK, Levin JB. Universal immunization of infants with low doses of a low-cost, plasma-derived hepatitis B vaccine in South Africa. Bull NU Hlth Org 2002; 80:277–281.
   Google Scholar
• Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection inAsia andAfrica. LancetInfectDis2007; 7:402–409.
   Google Scholar
• Mphahlele MJ. HIV and HBV interaction: Implications for Hepatitis B prevention and control. In: Raghunath D, Nayak R, eds. Proceedings of the Sixth Sir Dorabji Tata Symposium on Viral Hepatitis, Bangalore, India, 10–11 March 2005. Sir Dorabji Tata Centre for Research in Tropical Diseases, 2006; 163–178. ISBN-07-061171–8.
   Google Scholar
• Selabe SG, Lukhwareni A, Song E, Leeuw YGM, Burnett RJ, Mphahlele MJ. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients. J Med Wro/ 2007; 79: 1650–1654.
   Google Scholar
• Burnett RJ. Hepatitis B virus and human immunodeficiency virus co-infection: impact on transmission and natural history of disease. South AffJEpidemiolInecKthis issue.
   Google Scholar